DEXAMETHASONE
Body System:
Manner of administration:Implantation
Restriction
Indication: Diabetic macular oedema (DMO)
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $1,212.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ozurdex | |||||
Body System:
Manner of administration:Implantation
Restriction
Indication: Non-infectious posterior segment uveitis
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 0 | DPMQ: $1,212.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ozurdex | |||||
Body System:
Manner of administration:Implantation
Restriction
Indication: Branch retinal vein occlusion with macular oedema
Treatment phase: Initial treatment
Restriction
Indication: Central retinal vein occlusion with macular oedema
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $1,212.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ozurdex | |||||
Body System:
Manner of administration:Implantation
Restriction (Streamlined authority code: 13387)
Indication: Branch retinal vein occlusion with macular oedema
Treatment phase: Continuing treatment
Restriction (Streamlined authority code: 13336)
Indication: Central retinal vein occlusion with macular oedema
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $1,212.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ozurdex | |||||
Body System:
Manner of administration:Implantation
Restriction (Streamlined authority code: 13428)
Indication: Diabetic macular oedema (DMO)
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 1 | # of repeats: 1 | DPMQ: $1,212.07 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Ozurdex | |||||